Understanding pre-exposure prophylaxis (PrEP) regimen use: Switching and discontinuing daily and event-driven PrEP among men who have sex with men

[1]  L. van der Hoek,et al.  Diverging trends in incidence of HIV versus other sexually transmitted infections in HIV-negative men who have sex with men (MSM) in Amsterdam. , 2019, AIDS.

[2]  M. Prins,et al.  Motives for choosing, switching and stopping daily or event‐driven pre‐exposure prophylaxis – a qualitative analysis , 2019, Journal of the International AIDS Society.

[3]  B. Vuylsteke,et al.  Daily and event‐driven pre‐exposure prophylaxis for men who have sex with men in Belgium: results of a prospective cohort measuring adherence, sexual behaviour and STI incidence , 2019, Journal of the International AIDS Society.

[4]  L. Cotte,et al.  First year of pre-exposure prophylaxis implementation in France with daily or on-demand tenofovir disoproxil fumarate/emtricitabine. , 2019, The Journal of antimicrobial chemotherapy.

[5]  E. Vittinghoff,et al.  Racial/Ethnic and HIV risk category disparities in PrEP discontinuation among patients in publicly-funded primary care clinics. , 2019, AIDS.

[6]  B. Marshall,et al.  Long‐term retention in pre‐exposure prophylaxis care among men who have sex with men and transgender women in the United States , 2019, Journal of the International AIDS Society.

[7]  A. Boyd,et al.  Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study. , 2019, The lancet. HIV.

[8]  K. Ryan,et al.  Interest in Switching to On-Demand HIV Pre-Exposure Prophylaxis (PrEP) Among Australian Users of Daily PrEP: An Online Survey , 2019, Open forum infectious diseases.

[9]  K. Mayer,et al.  Patterns and clinical consequences of discontinuing HIV preexposure prophylaxis during primary care , 2019, Journal of the International AIDS Society.

[10]  S. Goodreau,et al.  Monitoring HIV pre-exposure prophylaxis use among men who have sex with men in Washington State: findings from an internet-based survey. , 2019, Sexually transmitted diseases.

[11]  S. Goodreau,et al.  Monitoring HIV Preexposure Prophylaxis Use Among Men Who Have Sex With Men in Washington State: Findings From an Internet-Based Survey. , 2019, Sexually transmitted diseases.

[12]  A. Ekström,et al.  A systematic review of adherence to oral pre-exposure prophylaxis for HIV – how can we improve uptake and adherence? , 2018, BMC Infectious Diseases.

[13]  B. Vuylsteke,et al.  Choosing Between Daily and Event-Driven Pre-exposure Prophylaxis: Results of a Belgian PrEP Demonstration Project , 2018, Journal of acquired immune deficiency syndromes.

[14]  W. Whittaker,et al.  Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics , 2018, HIV medicine.

[15]  K. Jonas,et al.  HIV Prevention After Discontinuing Pre-Exposure Prophylaxis: Conclusions From a Case Study , 2018, Front. Public Health.

[16]  A. Hogewoning,et al.  Men who have sex with men more often chose daily than event‐driven use of pre‐exposure prophylaxis: baseline analysis of a demonstration study in Amsterdam , 2018, Journal of the International AIDS Society.

[17]  R. D. De Boni,et al.  Retention, engagement, and adherence to pre-exposure prophylaxis for men who have sex with men and transgender women in PrEP Brasil: 48 week results of a demonstration study. , 2018, The lancet. HIV.

[18]  M. Mimiaga,et al.  Exploring strategies for PrEP adherence and dosing preferences in the context of sexualized recreational drug use among MSM: a qualitative study , 2018, AIDS care.

[19]  A. McNulty,et al.  Baseline Preferences for Daily, Event-Driven, or Periodic HIV Pre-Exposure Prophylaxis among Gay and Bisexual Men in the PRELUDE Demonstration Project , 2017, Front. Public Health.

[20]  C. B. Hare,et al.  Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation , 2016, Journal of acquired immune deficiency syndromes.

[21]  R. Grant,et al.  Effectiveness and safety of oral HIV preexposure prophylaxis for all populations , 2016, AIDS.

[22]  M. Mimiaga,et al.  Seasons of Risk: Anticipated Behavior on Vacation and Interest in Episodic Antiretroviral Pre-exposure Prophylaxis (PrEP) Among a Large National Sample of U.S. Men Who have Sex with Men (MSM) , 2016, AIDS and Behavior.

[23]  Jasmine Travers,et al.  eHealth Interventions for HIV Prevention in High-Risk Men Who Have Sex With Men: A Systematic Review , 2014, Journal of medical Internet research.

[24]  Christopher H. Jackson,et al.  Multi-State Models for Panel Data: The msm Package for R , 2011 .

[25]  T. Patterson,et al.  Club Drugs as Causal Risk Factors for HIV Acquisition Among Men Who Have Sex with Men: A Review , 2006, Substance use & misuse.